Endogenous endophthalmitis: A 10-year review of culture-positive cases in Northern China

Ocular Immunology and Inflammation

Volumn 18, Issue 2, 2010, Pages 133-138

  Zhang, Han ^a   Liu, Zheli ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Causative organism; Endogenous endophthalmitis; Predisposing medical conditions; Treatment

Indexed keywords

AMPHOTERICIN B; CEFTAZIDIME; CIPROFLOXACIN; FLUCONAZOLE; PENICILLIN G; VANCOMYCIN;

ADULT; AGED; ARTICLE; ASPERGILLUS; BACTERIUM CULTURE; BACTERIUM ISOLATION; CANDIDA; CHINA; CLINICAL ARTICLE; DIABETES MELLITUS; ENDOGENOUS ENDOPHTHALMITIS; ENDOPHTHALMITIS; EVISCERATION; FEMALE; FUNGUS ISOLATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; MALE; MEDICAL RECORD REVIEW; NONHUMAN; TREATMENT DURATION; TREATMENT OUTCOME; VISUAL ACUITY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIA; CHINA; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; EYE INFECTIONS, FUNGAL; FEMALE; FLUCONAZOLE; FUNGI; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; VISUAL ACUITY; VITRECTOMY;

EID: 77950586773     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273940903494717     Document Type: Article

References (30)

1. Shrader SK, Band JD, Lauter CB, et al. The clinical spectrum of endophthalmitis: incidence, predisposing factors, and features influencing outcome. J Infect Dis. 1990;162:115-120.
2. Leibovitch I, Lai T, Raymond G, et al. Endogenous endophthalmitis: a 13-year review at a tertiary hospital in South Australia. Scand J Infect Dis. 2005;37:184-189.
3. Jackson TL, Eykyn SJ, Graham EM, et al. Endogenous bacterial endophthalmitis: A 17-y prospective series and review of 267 reported cases. Surv Ophthalmol. 2003;48:403-423.
4. Okada AA, Johnson RP, Liles WC, et al. Endogenous bacterial endophthalmitis: report of a ten-year retrospective study. Ophthalmology. 1994;101:832-838.
5. Binder MI, Chua J, Kaiser PK, et al. Endogenous endophthalmitis: an 18-year review of culture-positive cases at a tertiary care center. Medicine. 2003;82:97-105.
6. Kostick DA, Foster RE, Lowder CY, et al. Endogenous endophthalmitis caused by Candida albicans in a healthy woman. Am J Ophthalmol. 1992;113:593-595.
7. Valluri S, Moorthy RS, Liggett PE, et al. Endogenous Aspergillus endophthalmitis in an immunocompetent individual. Int Ophthalmol. 1993;17:131-135.
8. Michelson JB, Friedlander MH. Endophthalmitis of drug abuse. Int Ophthalmol Clin. 1987;27:120-126.
9. Weishaar PD, Flynn HW Jr, Murray TG, et al. Endogenous Aspergillus endophthalmitis: clinical features and treatment outcomes. Ophthalmology. 1998;105:57-65.
10. Wong JS, Chan TK, Lee HM, et al. Endogenous bacterial endophthalmitis: an East Asian experience and a reappraisal of a severe ocular affliction. Ophthalmology. 2000;107:1483-1491.
11. Schiedler V, Scott IU, Flynn HW Jr, et al. Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes. Am J Ophthalmol. 2004;137:725-731.
12. Krishna R, Amuh D, Lowder CY, et al. Should all patients with candidemia have an ophthalmic examination to rule out ocular candidiasis? Eye. 2000;14:30-34.
13. Rao NA, Hidayat AA. Endogenous mycotic endophthalmitis: variations in clinical and histopathologic changes in candidiasis compared with aspergillosis. Am J Ophthalmol. 2001;132:244-251
14. Lundquist O, Osterlin S. Glucose concentration in the vitreous of nondiabetic and diabetic human eyes. Graefes Arch Clin Exp Ophthalmol. 1994;232:71-74.
15. DiMattio J, Zadunaisky JA, Altszuler N. Onset of changes in glucose transport across ocular barriers in streptozotocin-induced diabetes. Invest Ophthalmol Vis Sci. 1984;25:820-826.
16. Tanaka M, Kobayashi Y, Takebayashi H, et al. Analysis of predisposing clinical and laboratory findings for the development of endogenous fungal endophthalmitis. Retina. 2001;21:203-209.
17. Essman TF, Flynn HW Jr, Smiddy WE, et al. Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis. Ophthalmic Surg Lasers. 1997;28:185-194.
18. Chen YJ, Kuo HK, Wu PC, et al. A 10-y comparison of endogenous endophthalmitis outcomes: an East Asian experience with Klebsiella pneumonia infection. Retina. 2004;24:383-390.
19. Shammas HF. Endogenous E. coli endophthalmitis. Surv Ophthalmol. 1977;21:429-435.
20. Barza M. Factors affecting the intraocular penetration of antibiotics. Scand J Infect Dis. (Suppl) 1978;14:151-159.
21. Louria DB, Dineen P. Amphotericin B in the treatment of disseminated moniliasis. JAMA. 1960;174:273-275.
22. Green WR, Bennett JE, Goos RD. Ocular penetration of amphotericin B: a report of laboratory studies and a case report of post-surgical cephalosporium endophthalmitis. Arch Ophthalmol. 1965;73:769.
23. Gallis HA, Drew RH, Pickard WW. Amphotericin B: 30 years of clinical experience. Rev Infect Dis. 1990;12:308-329.
24. Souri EN, Green R. Intravitreal amphotericin B toxicity. Am J Ophthalmol. 1974;78:77-81.
25. Savani DV, Perfect JR, Cobo LM. Penetration of new azole compounds in the eye and efficacy in experimental Candida endophthalmitis. Antimicrobiol Agents Chemother. 1987;31:6-10.
26. Akler ME, Vellend H, McNeely DM, et al. Use of fluconazole in the treatment of candidal endophthalmitis. Clin Infect Dis. 1995;20: 657-664.
27. Christmas N, Smiddy W. Vitrectomy and systemic fluconazole for treatment of endogenous fungal endophthalmitis. Ophthalmic Surg Lasers. 1996;27:1012-1018.
28. Luttrull J, Wan WL, Kuback B, et al. Treatment of ocular fungal infections with oral fluconazole. Am J Ophthalmol. 1995;119:477-481.
29. Romero CF, Rai MK, Lowder CY, et al. Endogenous endophthalmitis: case report and brief review. Am Fam Physician. 1999;60:510-514.
30. Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study: a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol. 1995;113:1479-1496.